John Stagg

John Stagg is a distinguished academic and researcher with extensive experience in the field of tumor immunology. Currently serving as Principal Investigator at CHUM - Centre hospitalier de l'Université de Montréal, Full Professor at Université de Montréal, and Senior Scientist at Institut du cancer de Montréal since August 2010, John Stagg has played a pivotal role in advancing cancer research. Additionally, positions include being a member of the Management Board at BioCanRx and serving on several scientific advisory boards, including Coherus BioSciences, Ability Biologics, Domain Therapeutics, and the Cancer Research Institute. With a Ph.D. from McGill University, earned in 2005, John Stagg co-founded Surface Oncology Inc. and has previously advised Tarus Therapeutics.